Product Information
RANOLAZINE ER 500 MG TABLET is a generic product labeled by i3 Pharmaceuticals, LLC, priced at $0.1609 per EA under NDC 72319002102. Its NADAC has been published 195 times since Nov 30, 2022.
FDA first approved this application on Apr 27, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
i3 Pharmaceuticals, LLCNDC
72319002102
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RANOLAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA213517FDA Approved
4/27/2022
TE Code
AB
On Market Since
6/15/2022
Pharmacological Classes
Price Statistics
The NADAC for RANOLAZINE ER 500 MG TABLET has been published 195 times since Nov 30, 2022, and over the history we have for it it has declined 36.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1609 per EA |
|---|---|
| All-time high | $0.2647 (Jan 10, 2024) |
| All-time low | $0.1581 (Jul 22, 2026) |
| 52-week high | $0.1743 |
| 52-week low | $0.1581 |
| Median price | $0.2096 |
| Average price | $0.2053 |
| Largest weekly change | +17.6% (Aug 21, 2024) |
| Weeks tracked | 195 |
| Tracking since | Nov 30, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RANOLAZINE ER 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RANOLAZINE ER 500 MG TABLET, manufactured by i3 Pharmaceuticals, LLC, is $0.1609 per EA (NDC 72319002102), effective Aug 19, 2026.
How has the price of RANOLAZINE ER 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for RANOLAZINE ER 500 MG TABLET has declined 36.4%. It has been tracked across 195 weekly CMS publications since Nov 30, 2022.
What are the highest and lowest recorded NADAC prices for RANOLAZINE ER 500 MG TABLET?
Since Nov 30, 2022, the NADAC for RANOLAZINE ER 500 MG TABLET has ranged from a low of $0.1581 (Jul 22, 2026) to a high of $0.2647 (Jan 10, 2024), with a median of $0.2096 per EA.
Are there cheaper alternatives to RANOLAZINE ER 500 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RANOLAZINE ER 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures RANOLAZINE ER 500 MG TABLET?
RANOLAZINE ER 500 MG TABLET (NDC 72319002102) is labeled by i3 Pharmaceuticals, LLC, and CMS classifies it as a generic product.